{
  "schema_version": "0.4",
  "ir_kind": "hl",
  "metadata": {
    "title": "Organoid growth media formulation",
    "source": {
      "type": "paper",
      "id": "s41467-025-68247-6.pdf"
    }
  },
  "resources": {
    "materials": [],
    "containers": [],
    "equipment": [],
    "samples": [
      {
        "id": "media1",
        "name": "Organoid growth media"
      }
    ],
    "data": []
  },
  "protocol": {
    "steps": [
      {
        "id": "s1",
        "op": "allocate",
        "inputs": [],
        "outputs": [
          {
            "kind": "sample",
            "id": "media1"
          }
        ],
        "params": {
          "container_type": "tube"
        },
        "annotations": {}
      },
      {
        "id": "s2",
        "op": "annotate",
        "inputs": [
          {
            "kind": "sample",
            "id": "media1"
          }
        ],
        "outputs": [
          {
            "kind": "sample",
            "id": "media1"
          }
        ],
        "params": {},
        "annotations": {
          "description": "Advanced DMEM/F12 supplemented with 1X Pen‑Strep, 10 mM HEPES, 1X GlutaMAX, 1X B‑27 Supplement (Thermo Fisher Scientific), 0.2 nM Wnt Surrogate protein, 5 nM Gastrin‑1 (Tocris), 1.25 mM N‑Acetyl‑L‑Cysteine (Sigma‑Aldrich), 10 mM Nicotinamide (Sigma‑Aldrich), 100 µg/mL Primocin (InvivoGen), 500 nM A 83‑01 (Tocris), 50 ng/mL recombinant human EGF (R&D Systems), 100 ng/mL recombinant human Noggin (R&D Systems), 250 ng/mL recombinant human R‑spondin 3 (Roche), 100 ng/mL recombinant human IGF1 (BioLegend), 50 ng/mL recombinant human FGF2 (PeproTech), and 10 µM Y‑27632."
        }
      }
    ],
    "start_step_id": "s1",
    "edges": [
      {
        "from": "s1",
        "to": "s2"
      }
    ],
    "detail_level": 0
  }
}